Revascularization of significant coronary artery disease in patients undergoing transcatheter aortic valve implantation: a systematic review and meta-analysis

Back

ESC Professional Premium Access

Revascularization of significant coronary artery disease in patients undergoing transcatheter aortic valve implantation: a systematic review and meta-analysis

Session: When valvular heart disease is not alone

Topic: Intervention

Speaker: Mr H. Aarts (Utrecht, NL)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Mr Hugo Aarts

University Medical Center Utrecht, Utrecht (Netherlands (The))

0 follower

6 more presentations in this session

Echocardiographic phenotype in severe aortic valve stenosis with and without cardiac amyloidosis: the AMY-TAVI trial.

Speaker: Professor J. Gonzalez Juanatey (Santiago de Compostela, ES)

Access

Abstract

Slides

Diagnostic performance of coronary CTA and CT-FFR for the detection of coronary artery disease in routine TAVI work-up

Speaker: Ms J. Peper (Nieuwegein, NL)

Access

Abstract

Slides

Periprocedural outcomes of transcatheter aortic valve replacement (TAVR) in patients with and without cardiac amyloidosis-analysis from 2016-2019 national inpatient sample

Speaker: Doctor S. Kambalapalli (Flint, US)

Access

Abstract

Slides

Adding troponin to echocardiography improves preoperative abscess detection in infective endocarditis. A REMOVE Trial analysis

Speaker: Doctor M. Diab (Rotenburg An Der Fulda, DE)

Access

Abstract

Slides

Incidence and predictors of transthyretin cardiac amyloidosis in patients with degenerative aortic stenosis

Speaker: Doctor W. Jaber (Cleveland, US)

Access

Abstract

Slides

Access the full session

When valvular heart disease is not alone

Speakers: Mr H. Aarts, Professor J. Gonzalez Juanatey, Ms J. Peper, Doctor S. Kambalapalli, Doctor M. Diab...

Access

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources